AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇲🇼
AMPICILLIN TRIHYDRATE in Malawi
7 products registered with PMRA — 0 active, 7 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| AMPILLIN 125MG/5ML SUSPENSION SUSPENSION | PMPB/PL72/67 | — | expired | 31 Mar 2025 |
| AMPECIN_DPS 125MG/5ML SUSPENSION SUSPENSION | PMPB/PL12/100 | — | expired | 31 Mar 2025 |
| AMPICILLIN 250MG CAPSULE CAPSULE | PMPB/PL12/1 | — | expired | 31 Mar 2025 |
| LACILLIN 250MG CAPSULE CAPSULE | PMPB/PL108/44 | — | expired | 31 Mar 2025 |
| MAHACILLIN_SACHET 250MG/3G SACHET POWDER FOR SUSPENSION POWDER FOR SUSPENSION | PMPB/PL455/45 | — | expired | 30 Jun 2019 |
| AMPIMAX 250MG CAPSULE CAPSULE | PMPB/PL69/4 | — | expired | 30 Jun 2005 |
| AMPIMAX 125MG/5ML DRY SYRUP DRY SYRUP | PMPB/PL69/3 | — | expired | 30 Jun 2005 |
AMPICILLIN TRIHYDRATE — PMRA Registration Details
PMRA (Malawi) has 7 registered products containing AMPICILLIN TRIHYDRATE, of which 0 are currently active. Data is sourced directly from the official PMRA drug register and refreshed daily.
Track AMPICILLIN TRIHYDRATE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.